Home / Fact sheets / Japan / Colorectal qualitative data
Check also the following factsheets: Japan, Breast, Cervical
Country fact sheet: Japan
COLORECTAL CANCER SCREENING PROGRAMME
Reporting year for qualitative data: | 2020 |
Source of qualitative data: | Directly from Programme |
Organization of screening | |
An individual/team/institution responsible to coordinate the programme: | Yes |
Dedicated budget for screening programme: | Yes |
Documented cancer screening policy: | Yes |
Nature of documentation of the policy: | Notification |
Year programme was initiated: | 1992 |
Programme introduction was preceded by a pilot: | No |
Screening tests provided free of charge: | No |
Diagnostic tests provided free of charge: | No |
Treatment services provided free of charge: | No |
Information system and data collection | |
System that collects data: | Aggregated |
• Identification of eligible population: | - |
• Screening participation: | Aggregated |
• Screening test results: | Aggregated |
• Further assessment: | Aggregated |
• Final pathology diagnosis: | Aggregated |
• Cancer staging: | Aggregated |
• Treatment: | No |
The information system exists at national or sub-national level: | Individual: Unknown Aggregated: National |
The information system collects data outside the programme (opportunistic screening/private sector): | No |
Cancer screening data is linked with population-based cancer registry (PBCR): | Yes |
Screening protocol | |
A screening protocol or guideline: | Yes |
Year of published/updated protocol: | 2008 |
Target age (min-max) and screening interval [months] for each test: | FIT (40-99 years / [12 months]) |
Invitations for screening and further assessment | |
Initiatives to create population awareness by the Health Ministry/Health Authority: | Small media campaign Dedicated website |
Invitations to eligible population: | Other |
Source of the eligible individuals identified: | - |
Method of invitation: | - |
Screening kit included with the invitation: | - |
Screen positive individuals actively contacted for further assessment: | Yes |
Individuals with a precancer or cancer diagnosis actively contacted: | Yes |
Quality Assurance (QA) of screening activities | |
Documented standard operating procedure/policy for QA: | Yes |
An individual/team/institution responsible for QA: | Yes |
Accreditation of endoscopy units: | Yes |
Accreditation of pathology services: | Yes |
Documented performance indicators: | Yes |
Reference standards for performance indicators: | Yes |
Evaluation reports published in the last five years: | Yes |
Performance indicators | |
Reporting year for quantitative data: | 2017 |
Source of quantitative data: | directly from programme |
FIT | gFOBT | Sigmoidoscopy | Colonoscopy | |
Target age and regional limitation if applicable: | 40-99 years | |||
Invitation coverage (%): | ||||
Participation rate (%): | ||||
Examination coverage (%): | 11.0 | |||
Completeness of data related to screening results (%): | 100.0 | |||
Completeness of data related to information about attendance to colonoscopy assessment (%): | ||||
Further assessment (diagnosis colonoscopy) rate (%): | 7.5 | |||
Further assessment participation rate (%): | 68.6 | |||
Detection rate of adenomas (x 1000): | 12.6 | |||
Detection rate of advanced adenomas (x 1000): | 1.9 | |||
Detection rate of colorectal cancers (x 1000): | 1.8 | |||
Positive Predictive Value of further assessment to detect adenomas (%): | 24.4 | |||
Positive Predictive Value of further assessment to detect advanced adenomas (%): | 3.7 | |||
Positive Predictive Value of further assessment to detect colorectal cancers (%): | 3.5 | |||
More quantitative data (Male - 2017/FIT) | ||||
More quantitative data (Women - 2017/FIT) |
Check also the following factsheets: Japan, Breast, Cervical